References
- Boyer KM, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol. 2005;192:564–571. doi:https://doi.org/10.1016/j.ajog.2004.07.031.
- Demar M, Ajzenberg D, Maubon D, et al. Fatal outbreak of human toxoplasmosis along the Maroni river: epidemiological, clinical, and parasitological aspects. Clin Infect Dis. 2007;45:e88–e95. doi:https://doi.org/10.1086/521246.
- Magaldi C, Elkis H, Pattoli D, et al. Outbreak of toxoplasmosis in a Paulist seminary in Braganza (Sao Paulo state). Clinical, serological and epidemiological aspects. Rev Saude Publica. 1967;1:141–171. doi:https://doi.org/10.1590/s0034-89101967000200003.
- Kean BH, Kimball AC, Christenson WN. An epidemic of acute toxoplasmosis. JAMA. 1969;208:1002–1004.
- Masur H, Jones TC, Lempert JA, et al. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am J Med. 1978;64:396–402. doi:https://doi.org/10.1016/0002-9343(78)90218-8.
- Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma investigation team. Lancet. 1997;350:173–177. doi:https://doi.org/10.1016/s0140-6736(96)11105-3.
- Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–508. doi:https://doi.org/10.2471/BLT.12.111732.
- McLeod REA. Management of congenital toxoplasmosis. Curr Pediatr Rep 2014;2:166–194.
- Phan KK, Jalbrzikowski J, Noble AG, et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008;146:375–384.
- Wallon M, Peyron F, Cornu C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56:1223–1231. doi:https://doi.org/10.1093/cid/cit032.
- Prusa AR, Kasper DC, Sawers L, et al. Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving. PLoS Negl Trop Dis. 2017;11:e0005648. doi:https://doi.org/10.1371/journal.pntd.0005648.
- Binquet C, Lejeune C, Seror V, et al. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLoS One. 2019;14:e0221709. doi:https://doi.org/10.1371/journal.pone.0221709.
- Stillwaggon E, Carrier CS, Sautter M, et al. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011;5:e1333. doi:https://doi.org/10.1371/journal.pntd.0001333.
- Lykins J, Li X, Levigne P, et al. Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-toxoplasma antibodies. PLoS Negl Trop Dis. 2018;12:e0006536. doi:https://doi.org/10.1371/journal.pntd.0006536.
- El Mansouri B, Rhajaoui M, Sebti F, et al. Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco. Bull Soc Pathol Exot. 2007;100:289–290.
- Laboudi M, El Mansouri B, Sebti F, et al. Risk factors of a positive serological test for toxoplasmosis in a pregnant women in Morocco. Parasite. 2009;16:71–72. doi:https://doi.org/10.1051/parasite/2009161071.
- El Bissati K, Levigne P, Lykins J, et al. Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect. 2018;7:165. doi:https://doi.org/10.1038/s41426-018-0164-4.
- Chapey E, Wallon M, Peyron F. Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM. Clin Chim Acta. 2017;464:200–201. doi:https://doi.org/10.1016/j.cca.2016.10.023.
- Begeman IJ, Lykins J, Zhou Y, et al. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl Trop Dis. 2017;11:e0005670. doi:https://doi.org/10.1371/journal.pntd.0005670.
- Villard O, Cimon B, L’Ollivier C, et al. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National reference center for toxoplasmosis. Diagn Microbiol Infect Dis. 2016;84:22–33. doi:https://doi.org/10.1016/j.diagmicrobio.2015.09.009.
- Errifaiy H, Moutaj R. Thèse No. X. Evaluation of knowledge, behavior and immunological status of pregnant women about toxoplasmosis: epidemiological study from Essaouira-Safi region, Faculty of Medicine and pharmacy. Morocco: Cadi Ayyad University; 2014.
- Messerer L, Bouzbid S, Gourbdji E, et al. Seroprevalence of toxoplasmosis in pregnant women in Annaba, Algeria. Rev Epidemiol Sante Publique. 2014;62:160–165. doi:https://doi.org/10.1016/j.respe.2013.11.072.
- Fakhfakh N, Kallel K, Ennigro S, et al. [Risk factors for Toxoplasma gondii and immune status of pregnant women: cause and effect? Tunis Med. 2013;91:188–190.
- Galal L, Ajzenberg D, Hamidovic A, et al. Toxoplasma and Africa: one parasite, two opposite population structures. Trends Parasitol. 2018;34:140–154. doi:https://doi.org/10.1016/j.pt.2017.10.010.
- Behnke MS, Khan A, Wootton JC, et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc. Natl Acad. Sci. USA. 2011;108:9631–9636. doi:https://doi.org/10.1073/pnas.1015338108.
- McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis. 2006;42:1383–1394. doi:https://doi.org/10.1086/501360.
- Cortes JA, Gómez JE, Silva PI, et al. Clinical practice guideline. integral care guidelines for the prevention, early detection and treatment of pregnancy, childbirth and puerperium complications: section on toxoplasmosis in pregnancy. Infectio. 2017;21:102–116.
- Gomez-Marin JE, de-la-Torre A, Angel-Muller E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis. 2011;5:e1195. doi:https://doi.org/10.1371/journal.pntd.0001195.